Averill-Bates Diana A, Chérif Anissa, Agostinelli Enzo, Tanel André, Fortier Guy
Département de chimie et biochimie, TOXEN, Université du Québec à Montréal, Case Postale 8888, Succursale Centre Ville, Montréal, Que., Canada H3C 3P8.
Biochem Pharmacol. 2005 Jun 15;69(12):1693-704. doi: 10.1016/j.bcp.2005.02.025.
Bovine serum amine oxidase (BSAO) oxidatively deaminates polyamines containing primary amine groups, spermidine and spermine, to form the cytotoxic products hydrogen peroxide and aldehyde(s). Polyamines are present at elevated levels in many tumor tissues. The aims of the study were to evaluate the anti-tumoral activities of native and immobilized BSAO in mouse melanoma and also to determine the mechanism of tumor cell death. C57BL mice received a subcutaneous injection of B16 melanoma cells to induce formation of tumors, prior to antitumor treatments with native and immobilized BSAO. The enzyme was immobilized in a poly(ethylene glycol) (PEG) biocompatible matrix. Antitumor treatments consisted of a single injection of enzyme into the tumor. When immobilized BSAO (2.5mU) was injected into the tumor, there was a marked decrease of 70% of the tumor growth. This was compared with a decrease of only 32% of tumor size when the same amount of native BSAO was administered. The type of cell death was analysed in tumors that were treated with native or immobilized BSAO. When tumors were treated with immobilized BSAO, there was induction of a high level of apoptosis (around 70%), compared to less than 10% with the native enzyme. Apoptotic cell death was assessed by nuclear chromatin condensation using Hoechst staining and labelling of externalized phosphatidylserine using Annexin V. However, native BSAO, probably due to a burst of cytotoxic products, induced a high level of necrosis of about 40%, compared to less than 10% with immobilized BSAO. In conclusion, the advantage is that immobilized BSAO can act by allowing the slow release of cytotoxic products, which induces tumor cell death by apoptosis rather than necrosis.
牛血清胺氧化酶(BSAO)可将含有伯胺基团的多胺(亚精胺和精胺)进行氧化脱氨,形成细胞毒性产物过氧化氢和醛类。多胺在许多肿瘤组织中含量升高。本研究的目的是评估天然和固定化BSAO在小鼠黑色素瘤中的抗肿瘤活性,并确定肿瘤细胞死亡的机制。在用天然和固定化BSAO进行抗肿瘤治疗之前,C57BL小鼠皮下注射B16黑色素瘤细胞以诱导肿瘤形成。该酶被固定在聚乙二醇(PEG)生物相容性基质中。抗肿瘤治疗包括向肿瘤内单次注射酶。当将固定化BSAO(2.5mU)注射到肿瘤中时,肿瘤生长明显下降了70%。相比之下,当给予相同量的天然BSAO时,肿瘤大小仅下降了32%。对用天然或固定化BSAO治疗的肿瘤中的细胞死亡类型进行了分析。当用固定化BSAO治疗肿瘤时,诱导了高水平的细胞凋亡(约70%),而天然酶诱导的细胞凋亡不到10%。通过使用Hoechst染色评估核染色质凝聚以及使用膜联蛋白V标记外化的磷脂酰丝氨酸来评估凋亡细胞死亡。然而,天然BSAO可能由于细胞毒性产物的爆发,诱导了约40%的高水平坏死,而固定化BSAO诱导的坏死不到10%。总之,优势在于固定化BSAO可以通过允许细胞毒性产物缓慢释放来发挥作用,从而通过凋亡而非坏死诱导肿瘤细胞死亡。